Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

David Russell‐Jones; Allan Vaag; O. Schmitz; Bipin Sethi; Nebojša Lalić

doi:10.1007/s00125-009-1472-y

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

David Russell‐Jones, Allan Vaag, O. Schmitz, Bipin Sethi, Nebojša Lalić, Slobodan Antić, Marija Zdravković, Gabriela Martinez Ravn, Rafael Simó

Springer Science+Business Media (2009) • Volume 52, Issue 10, Pages 2046-2055

PDF Available

Abstract

The study was funded by Novo Nordisk A/S.

Quick Actions

Read Full Paper

Publication Info

DOI

10.1007/s00125-009-1472-y

Language

English

Topic

Diabetes Treatment and Management

Keywords

Medicine, Metformin, Sulfonylurea, Liraglutide, Insulin glargine, Type 2 Diabetes Mellitus, Placebo, Internal medicine, Diabetes mellitus, Exenatide, Insulin, Type 2 diabetes, Endocrinology, Alternative medicine

Published

August 13, 2009

Citations

822 citations

FWCI

73.22

External Resources

DOI Link OpenAlex

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Abstract

Quick Actions

Publication Info

External Resources

Suggested Papers

The Role of Polyphenols in Abiotic Stress Tolerance and Their Antioxidant Properties to Scavenge Reactive Oxygen Species and Free Radicals

Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data

Global Leprosy Status in 2020: Still Losing Touch

Suggested Papers

Suggested Papers

The Role of Polyphenols in Abiotic Stress Tolerance and Their Antioxidant Properties to Scavenge Reactive Oxygen Species and Free Radicals

Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data

Global Leprosy Status in 2020: Still Losing Touch